A candidate-identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate


Kutsal Y. G. , Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., Kirazli Y., et al.

3rd Joint Meeting of the European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society, Athens, Yunanistan, 7 - 11 May 2011, cilt.48